Ooplasmic and nuclear transfer to prevent mitochondrial DNA disorders: Conceptual and normative issues

Human Reproduction Update

Volumn 14, Issue 6, 2008, Pages 669-678

  Bredenoord, A L ^a   Pennings, G ^b   De Wert, G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Ethics; Genetic disorders; Mitochondria; Nuclear transfer

Indexed keywords

CELL NUCLEUS DNA;

ARTICLE; CELL NUCLEUS TRANSPLANTATION; CONCEPT FORMATION; DNA MODIFICATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; GENE MUTATION; GENETIC SELECTION; GERM LINE; HEALTH CARE; HUMAN; MEDICAL ETHICS; MITOCHONDRIAL DNA DISORDER; MOLECULAR CLONING; MORALITY; OOCYTE DONATION; PATIENT SAFETY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SOCIAL JUSTICE;

CLONING, ORGANISM; CYTOPLASM; DNA, MITOCHONDRIAL; EMBRYO RESEARCH; HUMANS; MITOCHONDRIAL DISEASES; NUCLEAR TRANSFER TECHNIQUES; OOCYTE DONATION; OOCYTES;

EID: 54449087057     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmn035     Document Type: Article

References (90)

1. Barnett A, McKie R. Babies with three parents ahead. Observer 2004, 17 October.
2. Barritt JA, Brenner CA, Malter HE, Cohen J. Mitochondria in human offspring derived from ooplasmic transplantation. Hum Reprod 2001a;16:513-516.
3. Barritt JA, Brenner CA, Malter HE, Cohen J. Rebuttal: Interooplasmic transfers in human. Reprod Biomed Online 2001b;3:47-48.
4. Barritt JA, Willadsen S, Brenner C, Cohen J. Cytoplasmic transfer in assisted reproduction. Hum Reprod Update 2001c;7:428-435.
5. Bonnicksen AL. Ethical and policy issues in human embryo twinning. Cambr Q Healtc Ethics 1995;4:268-284.
6. Bonnicksen AL. The politics of germline therapy. Nat Genet 1998; 19:10-11.
7. Bowles EJ, Campbell KH, St John JC. Nuclear transfer: Preservation of a nuclear genome at the expense of its associated mtDNA genome(s). Curr Top Dev Biol 2007;77:251-290.
8. Bowles EJ, Tecirlioglu RT, French AJ, Holland MK, St John JC. Mitochondrial DNA transmission and transcription after somatic cell fusion to one or more cytoplasts. Stem Cells 2008;26:775-782.
9. van der Burg W. The slippery-slope argument. J Clin Ethics 1992; 3:256-268.
10. Burgess JA. The great slippery-slope argument. J Med Ethics 1993;129: 169-174.
11. Bredenoord AL, Pennings G, Smeets HJ, de Wert G. Dealing with uncertainties. Ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update 2008a;14:83-94.
12. Bredenoord AL, Dondorp W, Pennings G, de Die-Smulders CEM, de Wert G. PGD to reduce reproductive risk: The case of mitochondrial DNA disorders. Hum Reprod 2008b; doi:10.1093/humrep/den290.
13. Brenner CA. Ooplasmic transplantation. J Assis Reprod Genet 2004;21:27-28.
14. Brenner CA, Barritt JA, Steen Willadsen DVM, Cohen J. Mitochondrial DNA heteroplasmy after human ooplasmic transplantation. Fertil Steril 2000;74:573-578.
15. Brock DW. Cloning human beings: An assessment of the ethical issues pro and con. In: Nussbaum MC, Sunstein CR (ed). Clones and Clones. Facts and Fantasies About Human Cloning. New York and London: W.W. Norton & Company, 1998. 141-164.
16. Brown DT, Herbert M, Lamb VK, Chinnery PF, Taylor RW, Lightowlers RN, Craven L, Cree L, Gardner JL, Turnbull DM. Transmission of mitochondrial DNA disorders: Possibilities for the future. Lancet 2006;368 87-89.
17. Buchanan A, Brock DW, Daniels N, Wikler D. From Chance to Choice. Genetics & Justice. Cambridge: Cambridge University Press, 2000.
18. Chinnery PF, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. Cochrane Database of Systematic Review 2006; Art. No.: CD004426. DOI: 10.1002/14651858.CD004426.pub2.
19. Cohen CB (ed). New Ways of Making Babies. The Case of Egg Donation. The National Advisory Board on Ethics in Reproduction. Bloomington and Indianapolis: Indiana University Press, 1996.
20. Cohen J, Tomkin G. The science, fiction, and reality of embryo-cloning. Kennedy Inst Ethics 1994;4:193-203.
21. Cohen J, Scott R, Schimmel T, Levron J, Willadsen S. Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs. Lancet 1997;350:186-187.
22. Cohen J, Scott R, Alikani M, Schimmel T, Munné S, Levron J, Wu L, Brenner C, Warner C, Willadsen S. Ooplasmic transfer in mature human oocytes. Mol Hum Reprod 1998;4:269-280.
23. Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Orvieto, 1997. ETS no 164.
24. Council of Europe. Additional Protocol to the Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine, and the Prohibition of Cloning Human Beings. Paris, 1998. ETS no 168.
25. Dawkins R. What's Wrong with Cloning? In: Nussbaum MC, Sunstein CR (eds). Clones and Clones. Facts and Fantasies Human Cloning. New York and London: W.W. Norton & Company, 1998,54-66.
26. Devolder K. What's in a name? Embryos, entities and ANTities in the stem cell debate. J Med Ethics 2006;32:43-48.
27. Dondorp WJ, de Wert GMWR. Embryonic Stem Cells Without Moral Pain? Health Council of the Netherlands. The Hague, Centre for Ethics and Health, 2005.
28. Dondorp WJ, de Wert GMWR. On waving the embryos banner. Embryonic stem cell research and moral reasoning in recent reports from the USA, the Netherlands and France. In: Gunning J, Hohn S (eds). Ethics, Law and Society, Vol. III, Aldershot: Ashgate, 2007.
29. Eisenberg VH, Schenker JG. Pregnancy in the older woman: Scientific and ethical aspects. Int J Gyn Obst 1997;55:163-169.
30. Feinberg J. 'The Child's Right to an Open Future'. In: Aiken W, LaFollette H (eds). Whose Child? Children's Rights, Parental Authority, and State Power. Totowa, NJ: Rowman and Littlefield, 1980. (Reprinted in Freedom & Fulfillment 1992).
31. Fulka J, Fulka H, St John JC. Transmission of mtDNA disorders: possibilities for the elimination of mutated mitochondria. Cloning Stem Cells 2007;9:47-50.
32. Gardner JL, Craven L, Turnbull DM, Taylor RW. Experimental strategies towards treating mitochondrial DNA disorders. Biosci Rep 2007; 27:139-150.
33. Graumann S, Haker H. Some conceptual and ethical comments on egg cell nuclear transfer. Politics Life Sci 1998;17:17-19.
34. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Cohen BH. Mitochondrial disease: A practical approach for primary care physicians. Pediatrics 2007;120:1326-1333.
35. Harris J. Enhancing Evolution. The Ethical Case for Making Better People. Princeton and Oxford: Princeton University Press, 2007.
36. Hawes SM, Sapienza C, Latham KE. Ooplasmic donation in humans. The potential for epigenetic modifications. Hum Reprod 2002;17 850-852.
37. Health Council of the Netherlands. Nuclear Transplantation in Cases of Mutations in Mitochondrial DNA. The Hague: Health Council of the Netherlands, 2001. Publication no 2001/07.
38. Holm S. A life in shadows: One reason why we should not clone humans. Camb Q Healthc Ethics 1998;7:160-162.
39. Holm S, Harris J. Precautionary principle stifles discovery. Nature 1999;400:398.
40. Howard CV, Saunders PT. Sensible precautions make good science.... Nature 1999;401:207.
41. Huang CC, Cheng TZ, Chang HH, Chang CC, Chen CI, Liu J, Lee MS. Birth after the injection of sperm and the cytoplasm of tripronucleate zygotes into metaphase II oocytes in patients with repeated implantation failure after assisted fertilization procedures. Fertil Steril 1999;72 702-706.
42. Human Fertilisation and Embryology Authority RO153. http://www.hfea.gov.uk/docs/ R0153_How_the_decision_was_made_to_licence_this_research_project_2_pdf.
43. Jacobs LJAM, De Wert G, Geraedts JPM, De Coo IFM, Smeets HJM. The transmission of OXPHOS disease and methods to prevent this. Hum Reprod Update 2006;12:119-136.
44. Kagawa Y, Hayashi JI. Gene therapy of mitochondrial diseases using human cytoplasts. Gene Ther 1997;4:6-10.
45. Krey L, Liu H, Zhang J, Grifo J. Strategies to Improve Pregnancy Outcome. Ann N Y Acad Sci 2001;943:26-33.
46. Lamb D. Down the Slippery Slope. London: Croom Helm, 1988.
47. Lanzendorf SE, Mayer JF, Toner J, Oehninger S, Saffan DS, Muasher S. Pregnancy following transfer of ooplasm from cryopreserved-thawed donor oocytes into recipient oocytes. Fertil Steril 1999;71: 575-577.
48. Lease LR, Winnier DA, Williams JT, Dyer TD, Almasy L, Mahaney MC. Mitochondrial genetic effects on latent class variables associated with susceptibility to alcoholism. BMC Genet 2005;6(Suppl 1):S158.
49. Malter HE. Improving eggs: More questions than answers. J Ass Reprod Genet 2002;19:118-120.
50. Mertes H, Permings G. Oocyte donation for stem cell research. Hum Reprod 2007;22:629-634.
51. Mertes H, Pennings G. Embryonic stem cell-derived gametes and genetic parenthood: A problematic relationship. Camb Q Healthc Ethics 2008;17:7-14.
52. McGleenan T. Human gene therapy and slippery slope arguments. J Med Ethics 1995;21:350-355.
53. Midgley M. Biotechnology and monstruosity: Why we should pay attention to the 'yuk factor'. Hastings Center Report 2000;30:7-15.
54. Munnich A, Rotig A, Chretien D, Cormier V, Bourgeron T, Bonnefont JP, Saudubray JM, Rustin P. Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis 1996;19:521-527.
55. Olsthoom-Heim ETM, de Wert GMWR, Winter HB, te Braake ThAM, Heineman MJ, Middelkamp A, Nierse CJ. Evaluatie Embryowet. Den Haag: ZonMw. Reeks evaluatie regelgeving: Deel 20, 2006.
56. Parens E, Juengst E. Inadvertently crossing the germ line. Science 2001;(292):397.
57. Parks JA. A closer look at reproductive technology and postmenopausal motherhood. Can Med Assoc J 1996;154:1189-1191.
58. Pennings G, de Wert G, Shenfield G, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 13: The welfare of the child in medically assisted reproduction. Hum Reprod 2007a;22 2585-2588.
59. Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 12: Oocyte donation for non-reproductive purposes. Hum Reprod 2007b;22:1210-1213.
60. Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 14: Equity of access to assisted reproductive technology. Hum Reprod 2008;23:772-774.
61. Peters PG. How Safe is Safe Enough? Obligations to the Children of Reproductive Technology. Oxford: Oxford University Press, 2004.
62. Poulton J, Kennedy S, Oakeshott P, St John J. Nuclear transfer to prevent mitochondrial DNA diseases. Lancet 2006;368:841.
63. President's Council on Bioethics. Human Cloning and Human Dignity. An Ethical Inquiry. Washington, DC: The President's Council on Bioethics, 2002.
64. President's Council on Bioethics. Reproduction and Responsibility. The Regulation of New Biotechnologies. Washington, DC: The President's Council on Bioethics, 2004.
65. Randerson J. Scientists seek to create 'three-parent babies'. New Scientist 2004; October 19.
66. Roberts RM. Prevention of Human Mitochondrial (mtDNA) Disease by Nucleus Transplantation Into an Enucleated Donor Oocyte. Am J Med Genet 1999;87:265-266.
67. Robertson JA. Children of Choice. Freedom and the new reproductive technologies. Princeton: Princeton University Press, 1994.
68. Robertson JA. Reconstituting eggs: The ethics of cytoplasm donation. Fertil Steril 1999;71:219-221.
69. Roubertoux PL, Sluyter F, Carlier M, Marcet B, Maarouf-Veray F, Chérif C, Marican C, Arrechi P, Godin F, Jamon, M et al. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nature Genet 2003;35:65-69.
70. Rubenstein DS, Thomasma DC, Schon EA, Zinaman JC. Germ-line therapy to cure mitochondrial disease: Protocol and ethics of in vitro ovum nuclear transplantation. Cambridge Q of Healthc Ethics 1995;4 316-339.
71. Salvi M. Shaping individuality: Human inheritable germ line gene modification. Theor Med 2001;22:527-542.
72. St John J, Lovell-Badge R. Human-animal cytoplasmic hybrid embryos, mitochondria, and an energetic debate. Nature Cell Biol 2007;9 988-992.
73. St John J, Lloyd RE, Bowles EJ, Thomas EC, Shourbagy SE. The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective. Reproduction 2004; 127:631-641.
74. Sunstein CR. The Paralyzing Principle. Regulation 2002-2003;winter:32-37.
75. Spikings EC, Alderson J, St John JC. Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer. Hum Reprod Update 2006;12:401-415.
76. Szebik I. Response to "Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation" by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, Michael J. Zinaman. Cambridge Q Healthc Ethics 1999; 8:369-374.
77. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6:389-402.
78. Templeton A. Ooplasmic transfer - proceed with care. N Engl J Med 2002; 346:773-775.
79. Thorburn DR, Dahl HHM. Mitochondrial disorders: Genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Gen (Semin Med Genet) 2001;106:101-114.
80. Thorburn DR, Dahl HHM, Singh KK. The pros and cons of mitochondrial manipulation in the human germ line. Mitochondrion 2001;1 123-127.
81. United Nations Universal Declaration on the Human Genome and Human Rights. 1997, http://www.portal.unesco.org/en/ev.php-URL_ID=13177 &URL_DO=DC_TOPIC&URL_SECTION=201.html.
82. United Nations Declaration on Human Cloning. 1998, http://daccessdds.un.org/doc/UNDOC/GEN/N04/493/06/PDF/ N0449306.pdf?OpenElement.
83. Van Blerkom J, Sinclair J, Davis P. Mitochondrial transfer between oocytes: Potential applications of mitochondrial donation and the issue of Heteroplasmy. Hum Reprod 1998;13:2857-2868.
84. De Wert G. Met her oog op de toekomst. Voortplantingstechnologie, erfelijkheidsonderzoek en ethiek. Thela Thesis. Amsterdam 1999.
85. De Wert G. Human cloning: The case of the (preimplantation) embryo, and ethical exploration. In: Gunning J (ed). Assisted Conception. Research, Ethics and Law. Ashgate Dartmouth: Aldershot, etc, 2000,83-07.
86. De Wert G. Humane embryonale stamcellen als Heilige Graal. Een ethische reflectie. Filosofie & Praktijk 2001;22:34-56 (in Dutch).
87. De Wert G. Handelingen met geslachtscellen en embryo's. In: Gezondheidsraad, Signalering Ethiek & Gezondheid 2003 2003;11-50.
88. De Wert G. Preimplantation genetic diagnosis: The ethics of intermediate cases. Hum Reprod 2005;20:3261-3266.
89. Wivel NA, Walters L. Human germ-line gene therapy: The case of its development and use. J Med and Phil 1993;14:593-612.
90. Zoon KC. Letter to sponsors/researchers-human cells used in therapy involving the transfer of genetic material by means other than the union of gamete nuclei. 2001, www.fda.gov/cber/Itr/cytotrans070601.htm